The Novo Nordisk Foundation Center for Basic Metabolic Research
OrganisationROR
Trials
Senolytics to Improve Osteoporosis Therapy
Collaborator, Phase 2, Active, not recruiting, 120 people, 30 Aug 2023
Collaborator, Phase 4, Completed, 105 people, 20 Feb 2013
Sources: clinicaltrials.gov
Funded papers
8 Sept 2026
NN0082202, NNF25OC0105033, 4 Sept 2026
NNF 190C0055250, NNF 22OC0078421, 4 Mar 2026
Sources: api.crossref.org